I-Corps: A Low-cost and Non-contact Respiration Monitoring Method for COVID-19 Screening and Prognosis

I-Corps：一种用于 COVID-19 筛查和预后的低成本、非接触式呼吸监测方法

• 批准号: 2336852
• 负责人: Sabit Ekin
• 金额: $ 5万
• 依托单位: Texas A&M Engineering Experiment Station
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-01-01 至 2024-07-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2336852&HistoricalAwards=false
• 关键词: Corps; Low; cost; Non; contact

The broader impact/commercial potential of this I-Corps project is the ability to monitor respiration using a low-cost and non-contact sensing method. Studies show that real-time health monitoring devices will reach a market value of over $65 billion by 2022. Given the high prevalence of lifestyle-associated disorders, long-term continuous monitoring of physiological parameters becomes important for many healthcare cases such as apnea and for human-computer-interaction applications. The anticipated benefits of the technology in the current COVID-19 outbreak include, but are not limited to, helping to reduce the load of current (expensive and limited) respiration monitoring medical equipment, being deployable in open-spaces and being highly desirable for the drastically increasing numbers of COVID-19 patients. Further, since respiration monitoring is a ubiquitous element of medicine, this work may also impact the entire health care community, from patients in their homes, to doctor’s offices, to large medical institutions and industries. This I-Corps project involves the technological advancement required to enable the proposed low-cost and non-contact respiration sensing method. This method represents a substantial departure from traditional approaches to wireless respiration monitoring and is poised to make significant contributions in this area. The proposed technology is timely given the critical worldwide impact of COVID-19. The proposed solution is adequately deployable in home environments (e.g. living rooms) and hospitals, etc. to remotely monitor respiration for COVID-19 screening and prognosis. The proposed approach allows very low-cost, safe, easy, continuous, and non-obtrusive gathering of respiration data — a critical input for cost-effective and proactive treatment and management of subjects with COVID-19 and other chronic respiratory conditions. This project will allow the team to better understand the unmet needs by conducting customer discoveries and interviews, develop a viable business model, and learn the desired features for developing a compelling minimum viable product.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

该I-Corps项目的更广泛的影响/商业潜力是能够使用低成本和非接触敏感性方法来监测呼吸。研究表明，到2022年，实时健康监测设备将达到超过650亿美元的市场价值。鉴于生活方式相关疾病的高度流行，长期连续监测物理参数对于许多医疗保健案例（例如呼吸暂停）和人类兼职者相互作用的应用变得很重要。该技术在当前的Covid-19爆发中的预期好处包括但不限于减少当前（昂贵且有限的）呼吸监测医疗设备的负载，可在开放空间中部署，并且对于大量的Covid-199患者而言是非常可取的。此外，由于呼吸监测是普遍存在的医学元素，因此这项工作也可能影响整个医疗保健社区，从家里的患者到医生办公室到大型医疗机构和行业。这个I-Corps项目涉及实现建议的低成本和非接触呼吸敏感方法所需的技术进步。这种方法代表了传统方法与无线呼吸监测的实质性不同，并被中毒以在这一领域做出重大贡献。鉴于Covid-19的全球影响至关重要，因此提出的技术是及时的。所提出的解决方案可以在家庭环境（例如客厅）和医院等中充分部署，以远程监测呼吸，以筛查和预后。所提出的方法允许对呼吸数据的非常低成本，安全，简单，连续和非引人注目的收集，这是对具有COVID-19和其他慢性呼吸疾病的受试者的成本效益和积极主动治疗以及管理的关键输入。该项目将使团队能够通过进行客户的发现和访谈，开发可行的业务模型，并学习开发引人注目的最低可行产品的所需功能，从而更好地了解未满足的需求。该奖项反映了NSF的法定任务，并被认为是通过基金会的知识分子优点和更广泛影响的审查标准来通过评估而被认为是宝贵的支持。